Berkshire Hathaway Inc shares have become more appealing due to a recent drop in stock price and a surge in book value, largely driven by the rally in Apple Inc shares.
Merck & Co is reportedly on the verge of acquiring EyeBio, an eye-drug company, for a sum of $1.3 billion. This acquisition is expected to significantly expand Merck's presence in the rapidly growing eye-care market.